Abstract | BACKGROUND:
Asthma is characterized by airflow limitation with chronic airway inflammation, hyperresponsiveness and mucus hypersecretion. NO is generated by three nitric oxide synthase (i/n/eNOSs) isoforms, but conflicting results have been reported using asthmatic mice treated with NOSs inhibitors and NOS-knockout mice. To elucidate the authentic role of NO/NOSs in asthma, we used asthmatic mice lacking all NOSs (n/i/eNOS(-/-)). METHODS: Wild-type and n/i/eNOS(-/-) mice were sensitized and challenged with ovalbumin. Pathological findings and expressions of interferon (IFN)-γ, interleukin (IL)-4, -5, -10, -13 and chemokines in the lung were evaluated. RESULTS: CONCLUSION: Using asthmatic n/i/eNOS(-/-) mice, NO plays important roles in accelerating bronchial eosinophilic inflammation and mucus hypersecretion in the pathophysiology of asthma.
|
Authors | Kentaro Akata, Kazuhiro Yatera, Ke-Yong Wang, Keisuke Naito, Takaaki Ogoshi, Shingo Noguchi, Takashi Kido, Yumiko Toyohira, Hiroaki Shimokawa, Nobuyuki Yanagihara, Masato Tsutsui, Hiroshi Mukae |
Journal | Lung
(Lung)
Vol. 194
Issue 1
Pg. 121-4
(Feb 2016)
ISSN: 1432-1750 [Electronic] United States |
PMID | 26685897
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ccl17 protein, mouse
- Chemokine CCL11
- Chemokine CCL17
- Chemokine CCL2
- Cytokines
- Interleukin-13
- Interleukin-5
- RNA, Messenger
- Interleukin-10
- Interleukin-4
- Interferon-gamma
- Nitric Oxide Synthase
|
Topics |
- Animals
- Asthma
(enzymology, genetics, pathology)
- Bronchitis
(immunology, pathology)
- Chemokine CCL11
(genetics)
- Chemokine CCL17
(genetics)
- Chemokine CCL2
(genetics)
- Cytokines
(genetics)
- Eosinophils
(immunology)
- Gene Expression
- Interferon-gamma
(genetics)
- Interleukin-10
(genetics)
- Interleukin-13
(genetics)
- Interleukin-4
(genetics)
- Interleukin-5
(genetics)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Mucus
(metabolism)
- Nitric Oxide Synthase
(deficiency, genetics)
- RNA, Messenger
(analysis)
|